In calendar year 2023, 340B covered entities purchased $66.3 billion in covered outpatient drugs under the 340B Program. The program enables safety-net providers to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services for the communities that they serve. The information below details the aggregate 340B purchases by covered entity type in 2023.| www.hrsa.gov
The 340B Drug Pricing Program has been used to inflate the profits of hospitals and pharmacies rather than providing savings.| Council For Citizens Against Government Waste
STOP THE SPECIAL INTEREST FEEDING FRENZY!| Council For Citizens Against Government Waste
